Answers from the Lab

Rondell Graham, M.B.B.S., describes Mayo Clinic Laboratories' new colorectal cancer panel. The assay covers more genes to better inform decision-making about prognosis, targeted therapies and a hereditary cancer syndrome.

Show Notes

(00:32)
 Could you provide us a little background about yourself?

(01:44)
 Could you give us a brief overview of the new Mayo complete colorectal panel assay?

(03:44)
 Can you go a little bit into more detail on guidelines and therapeutic implications concerning these specific genes? 

 (06:09)
 Which patients should have this testing?

(08:00)
 Are there any last pieces you'd like to add about the new Mayo Clinic colorectal cancer assay?

What is Answers from the Lab?

A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.